πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7132271

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7128895

Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnost

The Regents of the University of California Β· Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125965

MRI probes of membrane potential

The Regents of the University of California Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125969

ETS-related gene overexpressed in human breast and epithelial cancers

The Regents of the University of California Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125857

Modulators of DNA cytosine-5 methyltransferase and methods for use thereof

The Regents of the University of California Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122714

Mouse models of human prostate cancer

The Regents of the University of California Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122579

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California Β· Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119223

Interleukin-1 and tumor necrosis factor-Ξ± modulators, synthesis of said modulators and th

The Regents of the University of California Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119105

Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

The Regents of the University of California Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115582

HoxD3 and HoxA3 compositions and methods for improved wound healing

The Regents of the University of California Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115560

Methods for modulating gastric secretion using prokineticin receptor antagonists

The Regents of the University of California Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112566

Systemic administration of Hypocretin-1

The Regents of the University of California Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112338

Cationic liposome delivery of taxanes to angiogenic blood vessels

The Regents of the University of California Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7108986

Glypican-1 in human breast cancer

The Regents of the University of California Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105560

Use of etodolac in the treatment of multiple myeloma

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105330

Human plasma hyaluronidase

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105183

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105171

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105156

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproli

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105641

MCP-1 receptor antibodies

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105561

Use of etodolac for the treatment of prostate cancer

The Regents of the University of California Β· Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101846

Methods and compositions for optimization of oxygen transport by cell-free systems

The Regents of the University of California Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7097835

Immunoselective targeting agents and methods of use thereof

The Regents of the University of California Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7098306

Method and compositions for treating hepatocellular cancer

The Regents of the University of California Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted